AU2012259080A1 - Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof - Google Patents
Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof Download PDFInfo
- Publication number
- AU2012259080A1 AU2012259080A1 AU2012259080A AU2012259080A AU2012259080A1 AU 2012259080 A1 AU2012259080 A1 AU 2012259080A1 AU 2012259080 A AU2012259080 A AU 2012259080A AU 2012259080 A AU2012259080 A AU 2012259080A AU 2012259080 A1 AU2012259080 A1 AU 2012259080A1
- Authority
- AU
- Australia
- Prior art keywords
- hydroxyvitamin
- antibody
- vitamin
- seq
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C(C=CC1=O)N1c(cc1C(O)=O)ccc1C(c(c(O1)c2)ccc2O)=C(C=C2)C1=CC2=O Chemical compound *C(C=CC1=O)N1c(cc1C(O)=O)ccc1C(c(c(O1)c2)ccc2O)=C(C=C2)C1=CC2=O 0.000 description 2
- XOGQYEDWYJQJBV-GWGZCEIESA-N CCC1=CC(CBr)C(C(CC2)[C@](C)(CC3)C2[C@H](C)C(OC)=O)C3[C@@H]1COC(C)=O Chemical compound CCC1=CC(CBr)C(C(CC2)[C@](C)(CC3)C2[C@H](C)C(OC)=O)C3[C@@H]1COC(C)=O XOGQYEDWYJQJBV-GWGZCEIESA-N 0.000 description 1
- WRMRAQBPFAXGNJ-AFQTZRRLSA-N C[C@@H](C(CC1)[C@@](C)(CC2)C1C1C2[C@@](C)(CCC(C2)OC(C)=O)C2=CC1)C(O)=O Chemical compound C[C@@H](C(CC1)[C@@](C)(CC2)C1C1C2[C@@](C)(CCC(C2)OC(C)=O)C2=CC1)C(O)=O WRMRAQBPFAXGNJ-AFQTZRRLSA-N 0.000 description 1
- JTRSJOGYXLFVPL-KSFPFNIZSA-N C[C@@H](C(CC1)[C@@](C)(CCC2)C1/C2=C/C=C(/C[C@H](CC1)[O]#C)\C1=C)C(O)=O Chemical compound C[C@@H](C(CC1)[C@@](C)(CCC2)C1/C2=C/C=C(/C[C@H](CC1)[O]#C)\C1=C)C(O)=O JTRSJOGYXLFVPL-KSFPFNIZSA-N 0.000 description 1
- OWIPDUKNFPTTFE-NGZXPDLHSA-N C[C@@H](C(CC1)[C@@](C)(CCC2)C1/C2=C/C=C(/C[C@H](CC1)[O]#C)\C1=C)C(OC)=O Chemical compound C[C@@H](C(CC1)[C@@](C)(CCC2)C1/C2=C/C=C(/C[C@H](CC1)[O]#C)\C1=C)C(OC)=O OWIPDUKNFPTTFE-NGZXPDLHSA-N 0.000 description 1
- LZCTVTOWMJBBKW-ZCRJYUETSA-N C[C@@H](C(CC1)[C@]2(C)C1C(/C=C\C(C1)=C(C)CC[C@@H]1O)=CCC2)C(OC)=O Chemical compound C[C@@H](C(CC1)[C@]2(C)C1C(/C=C\C(C1)=C(C)CC[C@@H]1O)=CCC2)C(OC)=O LZCTVTOWMJBBKW-ZCRJYUETSA-N 0.000 description 1
- NTPSLMPIZJAWGJ-NCTVEUPOSA-N C[C@@H](C(CC1)[C@]2(C)C1C1=CC=C(C[C@H](CC3)O)C3C1CC2)C(OC)=O Chemical compound C[C@@H](C(CC1)[C@]2(C)C1C1=CC=C(C[C@H](CC3)O)C3C1CC2)C(OC)=O NTPSLMPIZJAWGJ-NCTVEUPOSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017203779A AU2017203779B2 (en) | 2011-05-20 | 2017-06-05 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488630P | 2011-05-20 | 2011-05-20 | |
| US61/488,630 | 2011-05-20 | ||
| US13/458,847 US8785603B2 (en) | 2011-05-20 | 2012-04-27 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| US13/458,847 | 2012-04-27 | ||
| PCT/US2012/038637 WO2012162165A2 (en) | 2011-05-20 | 2012-05-18 | Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017203779A Division AU2017203779B2 (en) | 2011-05-20 | 2017-06-05 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2012259080A1 true AU2012259080A1 (en) | 2013-10-31 |
Family
ID=47217992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012259080A Abandoned AU2012259080A1 (en) | 2011-05-20 | 2012-05-18 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| AU2017203779A Active AU2017203779B2 (en) | 2011-05-20 | 2017-06-05 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017203779A Active AU2017203779B2 (en) | 2011-05-20 | 2017-06-05 | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US8785603B2 (enExample) |
| EP (1) | EP2710376B1 (enExample) |
| JP (2) | JP2014516540A (enExample) |
| KR (1) | KR102032531B1 (enExample) |
| CN (1) | CN103857698B (enExample) |
| AU (2) | AU2012259080A1 (enExample) |
| ES (1) | ES2710449T3 (enExample) |
| WO (1) | WO2012162165A2 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8785603B2 (en) * | 2011-05-20 | 2014-07-22 | Siemens Healthcare Diagnostics Inc. | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| CN108524919A (zh) | 2012-05-17 | 2018-09-14 | 延伸生物科学股份有限公司 | 用于改进的药物递送的载体 |
| CN103588872B (zh) * | 2012-08-13 | 2016-01-06 | 北京博晖创新光电技术股份有限公司 | 一种维生素d合成抗原、其制备方法及应用 |
| US9618523B2 (en) * | 2013-02-28 | 2017-04-11 | Siemens Healthcare Diagnostics Inc. | Methods and reagents for determining isomeric analytes |
| US20140273021A1 (en) | 2013-03-14 | 2014-09-18 | Enzo Biochem, Inc. | Vitamin d assays |
| US20140308751A1 (en) * | 2013-04-12 | 2014-10-16 | Siemens Healthcare Diagnostics Inc. | Assays for Analyte Homologs |
| US20160178614A1 (en) * | 2013-08-02 | 2016-06-23 | Siemens Healthcare Diagnostics Inc. | Cell-based control and method |
| EP3177297B1 (en) | 2014-06-27 | 2021-04-07 | Siemens Healthcare Diagnostics Inc. | Compositions relating to vitamin d |
| AU2015280288B2 (en) * | 2014-06-27 | 2019-07-11 | Siemens Healthcare Diagnostics Inc. | Assays for vitamin D epimers |
| AU2015280292B2 (en) * | 2014-06-27 | 2019-08-01 | Siemens Healthcare Diagnostics Inc. | Binding partners specific for vitamin D epimers |
| EP3161005B1 (en) | 2014-06-27 | 2020-11-25 | Siemens Healthcare Diagnostics Inc. | Binding partners specific for vitamin d epimers in vitamin d assays |
| CN104062440B (zh) * | 2014-06-30 | 2016-05-11 | 韩雅君 | 一种快速检测维生素d的试纸条 |
| CN104098493A (zh) * | 2014-06-30 | 2014-10-15 | 湖南华腾制药有限公司 | 一种维生素d衍生物的制备方法 |
| EP3168619B1 (en) * | 2014-07-10 | 2021-10-20 | Shenzhen New Industries Biomedical Engineering Co., Ltd. | Detection agent for detecting 25-hydroxy vitamin d, preparation method and use |
| CN104076155B (zh) * | 2014-07-10 | 2016-08-31 | 深圳市新产业生物医学工程股份有限公司 | 用于检测25-羟基维生素d的检测剂及制备方法和应用 |
| WO2016065042A1 (en) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Therapeutic vitamin d conjugates |
| US9616109B2 (en) | 2014-10-22 | 2017-04-11 | Extend Biosciences, Inc. | Insulin vitamin D conjugates |
| US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
| WO2017127833A1 (en) | 2016-01-22 | 2017-07-27 | Affimedix, Inc. | Device for detection of vitamin d metabolites |
| US10338084B2 (en) | 2016-04-07 | 2019-07-02 | Quidel Corporation | Processing reagent and use thereof in assays for detection of analytes associated with a binding protein |
| CN107325173A (zh) * | 2016-04-28 | 2017-11-07 | 上海惠斯生物科技有限公司 | 一种25羟基维生素d3人工抗原、制备方法及应用 |
| CN106199016A (zh) * | 2016-06-30 | 2016-12-07 | 深圳市亚辉龙生物科技股份有限公司 | 25‑羟基维生素d化学发光免疫检测试剂盒及其制备方法 |
| WO2018006268A1 (zh) * | 2016-07-05 | 2018-01-11 | 深圳市亚辉龙生物科技股份有限公司 | 吖啶标记结合物及其制备方法、化学发光试剂盒 |
| WO2018006264A1 (zh) * | 2016-07-05 | 2018-01-11 | 深圳市亚辉龙生物科技股份有限公司 | 吖啶标记结合物及其制备方法、化学发光试剂盒 |
| CN106501535B (zh) * | 2016-11-30 | 2018-11-09 | 迪瑞医疗科技股份有限公司 | 一种ans盐复合释放剂与检测血液中皮质醇的试剂盒 |
| CN108205064B (zh) * | 2018-03-28 | 2020-08-21 | 北京丹大生物技术有限公司 | 25ohd3检测试剂、试剂盒及其检测方法 |
| CN108709993B (zh) * | 2018-04-02 | 2021-03-26 | 深圳上泰生物工程有限公司 | 一种胶乳增强免疫比浊检测试剂盒及其制备和检测方法 |
| EP4010005A4 (en) * | 2019-08-09 | 2022-11-23 | Siemens Healthcare Diagnostics Inc. | HOG-TCN1 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR PRODUCTION AND USE |
| CN110713533B (zh) * | 2019-11-26 | 2021-03-16 | 杭州隆基生物技术有限公司 | 一种25-羟基维生素d3抗原及其制备方法 |
| US20230115540A1 (en) * | 2020-03-06 | 2023-04-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Tumor targeted fluorescence guidance for intraoperative margin assessment |
| CN111351945B (zh) * | 2020-03-18 | 2021-04-23 | 东南大学 | 维生素d结合蛋白作为标志物在精神疾病抑郁症诊断中的应用 |
| JP7413624B2 (ja) * | 2020-07-21 | 2024-01-16 | 株式会社ファンケル | 血清ビタミンｄ代謝物の濃度の推定方法 |
| CN113999311B (zh) * | 2020-07-28 | 2022-11-04 | 东莞市朋志生物科技有限公司 | 可特异性结合25-羟基维生素d的抗体、其应用以及诊断试剂盒 |
| CN112624947B (zh) * | 2021-01-25 | 2023-09-08 | 福建万菇生物科技有限公司 | 一种利用绣球菌子实体提取高含量维生素d2的方法 |
| EP4416505A4 (en) * | 2021-10-13 | 2025-05-14 | Siemens Healthcare Diagnostics, Inc. | DHEAS ASSAY, REAGENTS THEREFOR, AND METHODS OF PRODUCTION AND USE THEREOF |
| IL319526A (en) | 2022-09-30 | 2025-05-01 | Extend Biosciences Inc | Long-acting parathyroid hormone |
| CN119080938B (zh) * | 2023-06-05 | 2025-06-24 | 东莞市朋志生物科技有限公司 | 抗25羟维生素d抗体、检测25羟维生素d的试剂和试剂盒 |
| CN117417455B (zh) * | 2023-10-30 | 2024-06-21 | 江南大学 | 一种特异性结合25-羟基维生素d3的抗原结合蛋白 |
| CN120137045A (zh) * | 2023-12-13 | 2025-06-13 | 菲鹏生物股份有限公司 | 抗25-羟基维生素d抗体及其用途 |
| CN120025402A (zh) * | 2025-02-20 | 2025-05-23 | 东南大学 | 一种靶向cldn6蛋白的多肽及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3267108D1 (en) | 1982-04-20 | 1985-12-05 | Teijin Ltd | Novel vitamin d3 derivatives, processes for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom |
| US4456553A (en) | 1982-05-07 | 1984-06-26 | Teijin Limited | Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom |
| JPH02274A (ja) | 1987-10-14 | 1990-01-05 | Toyo Jozo Co Ltd | 新規な２５−ヒドロキシビタミンｄ↓３誘導体およびその製造法およびそれを用いた定量法 |
| FR2631025B1 (fr) | 1988-05-04 | 1991-04-12 | Ire Medgenix Sa | Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3 |
| GB9325415D0 (en) | 1993-12-13 | 1994-02-16 | Res Inst Medicine Chem | Chemical compounds |
| US5821020A (en) | 1995-07-14 | 1998-10-13 | Nhh Biologics | Vitamin D assay |
| CA2279590A1 (en) | 1997-02-13 | 1998-08-20 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin d compounds |
| DE69920897T2 (de) | 1998-04-28 | 2005-10-13 | Smithkline Beecham Corp. | Monoklonale antikörper mit verringerter immunisierungsfähigkeit |
| JP4187929B2 (ja) | 1998-06-25 | 2008-11-26 | イムンディアグノスティック アクチェンゲゼルシャフト | 機能性ビタミンＤ誘導体の製造方法および２５−ヒドロキシおよび１α，２５−ジヒドロキシビタミンＤ代謝物の検出用試薬セット |
| JP3589912B2 (ja) | 1999-09-03 | 2004-11-17 | 泰久 福井 | ホスファチジルイノシトール−３，４−二リン酸を認識するモノクローナル抗体 |
| GB0029729D0 (en) * | 2000-12-06 | 2001-01-17 | Ids Ltd | Method for detection of vitamin D metabolites |
| US7087395B1 (en) | 2001-01-16 | 2006-08-08 | Quest Diagnostics Investments Incorporated | Vitamin D assay |
| US7630836B2 (en) | 2001-05-30 | 2009-12-08 | The Kitasato Institute | Polynucleotides |
| USH2220H1 (en) | 2001-08-10 | 2008-07-01 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| EP1612224B1 (en) | 2004-06-29 | 2012-03-07 | B.R.A.H.M.S GmbH | Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| US20080148432A1 (en) | 2005-12-21 | 2008-06-19 | Mark Scott Abad | Transgenic plants with enhanced agronomic traits |
| JP4852614B2 (ja) | 2005-09-29 | 2012-01-11 | エフ．ホフマン−ラ ロシュ アーゲー | ビタミンｄ化合物のための放出試薬 |
| WO2007039193A1 (en) * | 2005-09-29 | 2007-04-12 | Roche Diagnostics Gmbh | Antibodies against 25-hydroxyvitamin d |
| ES2482145T3 (es) | 2006-03-29 | 2014-08-01 | King's College London | Anticuerpos agonistas contra TSHR |
| ATE452343T1 (de) | 2006-06-06 | 2010-01-15 | Hoffmann La Roche | Verbesserte vitamin-d-messung |
| US20080148421A1 (en) | 2006-12-14 | 2008-06-19 | Monsanto Technology Llc | Plants and seeds of corn variety lh361 |
| PT2126586E (pt) | 2007-02-01 | 2010-09-17 | Immundiagnostik Ag | Determinação directa de vitamina d no soro ou plasma |
| CA2708407A1 (en) | 2007-12-13 | 2009-07-02 | Shanghai Guojian Bio-Tech Institute | Humanized anti-human cd34 antibody, the preparation method and uses thereof |
| WO2009099176A1 (ja) | 2008-02-08 | 2009-08-13 | Immunas Pharma, Inc. | Aβオリゴマーに特異的に結合する抗体およびその利用 |
| US20110212534A1 (en) | 2008-08-11 | 2011-09-01 | Taylor Robert L | Methods for determining levels of 1,25 dihydroxy vitamin d2 and d3 |
| JP2013508287A (ja) | 2009-10-14 | 2013-03-07 | ヤンセン バイオテツク，インコーポレーテツド | 抗体を親和性成熟する方法 |
| UA106771C2 (uk) | 2009-10-16 | 2014-10-10 | Ле Лаборатуар Сервьє | Моноклональні антитіла до прогастрину та їх використання |
| US20110097733A1 (en) * | 2009-10-27 | 2011-04-28 | Michel Anciaux | Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
| US8785603B2 (en) * | 2011-05-20 | 2014-07-22 | Siemens Healthcare Diagnostics Inc. | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
-
2012
- 2012-04-27 US US13/458,847 patent/US8785603B2/en active Active
- 2012-05-18 AU AU2012259080A patent/AU2012259080A1/en not_active Abandoned
- 2012-05-18 EP EP12789177.8A patent/EP2710376B1/en active Active
- 2012-05-18 CN CN201280024421.7A patent/CN103857698B/zh active Active
- 2012-05-18 WO PCT/US2012/038637 patent/WO2012162165A2/en not_active Ceased
- 2012-05-18 KR KR1020137033893A patent/KR102032531B1/ko active Active
- 2012-05-18 ES ES12789177T patent/ES2710449T3/es active Active
- 2012-05-18 JP JP2014512897A patent/JP2014516540A/ja active Pending
-
2014
- 2014-07-18 US US14/335,686 patent/US20140336156A1/en not_active Abandoned
-
2016
- 2016-09-29 JP JP2016191362A patent/JP6404876B2/ja active Active
-
2017
- 2017-06-05 AU AU2017203779A patent/AU2017203779B2/en active Active
-
2018
- 2018-03-07 US US15/915,001 patent/US10837973B2/en active Active
-
2020
- 2020-11-03 US US17/087,914 patent/US11815517B2/en active Active
-
2023
- 2023-10-12 US US18/486,137 patent/US12379386B2/en active Active
-
2024
- 2024-12-11 US US18/976,830 patent/US20250110139A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2710376A4 (en) | 2015-04-15 |
| EP2710376A2 (en) | 2014-03-26 |
| US20130059825A1 (en) | 2013-03-07 |
| AU2017203779B2 (en) | 2019-08-01 |
| AU2017203779A1 (en) | 2017-06-22 |
| ES2710449T3 (es) | 2019-04-25 |
| JP2014516540A (ja) | 2014-07-17 |
| EP2710376B1 (en) | 2018-11-14 |
| CN103857698B (zh) | 2016-09-21 |
| US20240094227A1 (en) | 2024-03-21 |
| KR20140086925A (ko) | 2014-07-08 |
| US20210055314A1 (en) | 2021-02-25 |
| US12379386B2 (en) | 2025-08-05 |
| US20140336156A1 (en) | 2014-11-13 |
| US20180372761A1 (en) | 2018-12-27 |
| WO2012162165A2 (en) | 2012-11-29 |
| WO2012162165A3 (en) | 2013-01-17 |
| JP6404876B2 (ja) | 2018-10-17 |
| CN103857698A (zh) | 2014-06-11 |
| US10837973B2 (en) | 2020-11-17 |
| KR102032531B1 (ko) | 2019-11-28 |
| US11815517B2 (en) | 2023-11-14 |
| US8785603B2 (en) | 2014-07-22 |
| US20250110139A1 (en) | 2025-04-03 |
| JP2017040659A (ja) | 2017-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12379386B2 (en) | Antibodies to 25-hydroxyvitamin D2 and D3 for detecting total 25-hydroxyvitamin D | |
| CN105624118B (zh) | 非交叉反应性抗IgG抗体 | |
| KR101720394B1 (ko) | 친화성 복합체에 대한 항체 | |
| US8283162B2 (en) | Antibodies relating to PIVKAII and uses thereof | |
| JP5981914B2 (ja) | Ｐｉｖｋａ−ｉｉに関する抗体およびその使用 | |
| WO2012064501A1 (en) | Hydroxycholesterol immunoassay | |
| KR101566090B1 (ko) | 항―인간 ＩｇＧ１ 항체 | |
| KR20170093820A (ko) | 비타민 d 의 측정을 위한 방법 | |
| CN114106159A (zh) | 一种SARS-CoV-2刺突蛋白抗体及其应用 | |
| CN114106163A (zh) | SARS-CoV-2病毒中和抗体及其用途 | |
| JP2011160696A (ja) | 修飾ヒトｉｇｆ−１／ｅペプチドに対する抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |